相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Flow cytometry analysis of synaptosomes from post-mortem human brain reveals changes specific to Lewy body and Alzheimer's disease
Nadia O. Postupna et al.
LABORATORY INVESTIGATION (2014)
Exosomes: A New Weapon to Treat the Central Nervous System
Luca Braccioli et al.
MOLECULAR NEUROBIOLOGY (2014)
Extracellular vesicles: emerging targets for cancer therapy
Pieter Vader et al.
TRENDS IN MOLECULAR MEDICINE (2014)
The Role of Clusterin in Amyloid-β-Associated Neurodegeneration
Rahul S. Desikan et al.
JAMA NEUROLOGY (2014)
Cross-Sectional and Longitudinal Relationships Between Cerebrospinal Fluid Biomarkers and Cognitive Function in People Without Cognitive Impairment From Across the Adult Life Span
Ge Li et al.
JAMA NEUROLOGY (2014)
A flow cytometric method for characterization of circulating cell-derived microparticles in plasma
Morten Hjuler Nielsen et al.
JOURNAL OF EXTRACELLULAR VESICLES (2014)
Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: An update from the Alzheimer's Association Global Biomarkers Consortium
Maria C. Carrillo et al.
ALZHEIMERS & DEMENTIA (2013)
APOE3, but Not APOE4, Bone Marrow Transplantation Mitigates Behavioral and Pathological Changes in a Mouse Model of Alzheimer Disease
Yue Yang et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Plasma Apolipoprotein A1 as a Biomarker for Parkinson Disease
Judy K. Qiang et al.
ANNALS OF NEUROLOGY (2013)
Microparticles: biomarkers and beyond
Dylan Burger et al.
CLINICAL SCIENCE (2013)
Neuronal Exosomal miRNA-dependent Translational Regulation of Astroglial Glutamate Transporter GLT1
Lydie Morel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Extracellular vesicles: Exosomes, microvesicles, and friends
Graca Raposo et al.
JOURNAL OF CELL BIOLOGY (2013)
Antagonism of Neuronal Prostaglandin E2 Receptor Subtype 1 Mitigates Amyloid β Neurotoxicity In Vitro
Xianwu Li et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Cerebrospinal fluid and plasma clusterin levels in Parkinson's disease
Karin D. van Dijk et al.
PARKINSONISM & RELATED DISORDERS (2013)
ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions
Philip B. Verghese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Preferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift
Mary Jo LaDu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2012)
Extensive p-Tau Pathology and SDS-Stable p-Tau Oligomers in Alzheimer's Cortical Synapses
Kristen M. Henkins et al.
BRAIN PATHOLOGY (2012)
Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimers disease
Carlos Cruchaga et al.
HUMAN MOLECULAR GENETICS (2012)
Small Molecule Structure Correctors Abolish Detrimental Effects of Apolipoprotein E4 in Cultured Neurons
Hung-Kai Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Exosome-associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease
Sudad Saman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The Exosome Secretory Pathway Transports Amyloid Precursor Protein Carboxyl-terminal Fragments from the Cell into the Brain Extracellular Space
Rocio Perez-Gonzalez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation
Eiron Cudaback et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol
R. Lacroix et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
AD synapses contain abundant Aβ monomer and multiple soluble oligomers, including a 56-kDa assembly
Sophie Sokolow et al.
NEUROBIOLOGY OF AGING (2012)
Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer's disease cortex
Sophie Sokolow et al.
NEUROBIOLOGY OF DISEASE (2012)
Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjects
Chera L. Maarouf et al.
NEUROLOGICAL RESEARCH (2012)
Exosome-Mediated Transfer of miR-133b from Multipotent Mesenchymal Stromal Cells to Neural Cells Contributes to Neurite Outgrowth
Hongqi Xin et al.
STEM CELLS (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Cerebrospinal Fluid Biomarkers for Parkinson Disease Diagnosis and Progression
Min Shi et al.
ANNALS OF NEUROLOGY (2011)
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
Bence Gyoergy et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Apolipoprotein E isoform-dependent microglia migration
Eiron Cudaback et al.
FASEB JOURNAL (2011)
Synapsin I Is an Oligomannose-Carrying Glycoprotein, Acts As an Oligomannose-Binding Lectin, and Promotes Neurite Outgrowth and Neuronal Survival When Released via Glia-Derived Exosomes
Shiwei Wang et al.
JOURNAL OF NEUROSCIENCE (2011)
A new microparticle size calibration standard for use in measuring smaller microparticles using a new flow cytometer
W. L. Chandler et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance
Joseph M. Castellano et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Proposed mechanism for lipoprotein remodelling in the brain
Chunjiang Yu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Reciprocal effects of apolipoprotein E alleles (ε2 AND ε4) on plasma lipid levels in normolipidemic subjects
M. Eto et al.
CLINICAL GENETICS (2010)
Flow Cytometric Analysis of Circulating Microparticles in Plasma
Aaron F. Orozco et al.
CYTOMETRY PART A (2010)
Insulin-Degrading Enzyme Sorting in Exosomes: A Secretory Pathway for a Key Brain Amyloid-beta Degrading Protease
Ayelen Bulloj et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Apolipoprotein A-I Deficiency Increases Cerebral Amyloid Angiopathy and Cognitive Deficits in APP/PS1ΔE9 Mice
Iliya Lefterov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Overexpression of Human Apolipoprotein A-I Preserves Cognitive Function and Attenuates Neuroinflammation and Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer Disease
Terry L. Lewis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
CSF markers of neurodegeneration in Parkinson's disease
Hana Prikrylova Vranova et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
Cell-Produced α-Synuclein Is Secreted in a Calcium-Dependent Manner by Exosomes and Impacts Neuronal Survival
Evangelia Emmanouilidou et al.
JOURNAL OF NEUROSCIENCE (2010)
CSF Aβ42 and tau in Parkinson's Disease with Cognitive Impairment
Thomas J. Montine et al.
MOVEMENT DISORDERS (2010)
Overcoming Limitations of Microparticle Measurement by Flow Cytometry
Romaric Lacroix et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2010)
Quantitation and Mapping of Cerebral Detergent-Insoluble Proteins in the Elderly
Randall L. Woltjer et al.
BRAIN PATHOLOGY (2009)
Human apolipoprotein A-I binds amyloid-β and prevents Aβ-induced neurotoxicity
Andrea C. Paula-Lima et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS
Robert W. Mahley et al.
JOURNAL OF LIPID RESEARCH (2009)
Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies?
S. Robert et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2009)
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
Denise Harold et al.
NATURE GENETICS (2009)
Membrane vesicles as conveyors of immune responses
Clotilde Thery et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Inhibition of γ-secretase causes increased secretion of amyloid precursor protein C-terminal fragments in association with exosomes
Robyn A. Sharples et al.
FASEB JOURNAL (2008)
Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
David R. Riddell et al.
JOURNAL OF NEUROSCIENCE (2008)
Enrichment of prion protein in exosomes derived from ovine cerebral spinal fluid
Laura J. Vella et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2008)
An Apolipoprotein A-1 gene promoter polymorphism associated with cognitive decline, but not with Alzheimer's disease
Nicole Helbecque et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2008)
CSF tau/Aβ42 ratio for increased risk of mild cognitive impairment -: A follow-up study
G. Li et al.
NEUROLOGY (2007)
The relation between apolipoprotein A-I and dementia - The Honolulu-Asia aging study
Jane S. Saczynski et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Alzheimer's disease β-amyloid peptides are released in association with exosomes
Lawrence Rajendran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice
Izumi Maezawa et al.
JOURNAL OF NEUROINFLAMMATION (2006)
Proteomic identification of lower apolipoprotein A-I in Alzheimer's disease
HC Liu et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2006)
Cardiovascular disease and Alzheimer's disease: common links
M. J. Stampfer
JOURNAL OF INTERNAL MEDICINE (2006)
Effect of domain interaction on apolipoprotein E levels in mouse brain
G Ramaswamy et al.
JOURNAL OF NEUROSCIENCE (2005)
Safety and acceptability of the research lumbar puncture
ER Peskind et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2005)
APOA1 polymorphism influences risk for early-onset nonfamiliar AD
H Vollbach et al.
ANNALS OF NEUROLOGY (2005)
Human apolipoprotein E4 alters the amyloid-β 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model
JD Fryer et al.
JOURNAL OF NEUROSCIENCE (2005)
Neuron-specific apolipoprotein E4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice
WJ Brecht et al.
JOURNAL OF NEUROSCIENCE (2004)
ApoE and clusterin cooperatively suppress Aβ levels and deposition:: Evidence that ApoE regulates extracellular Aβ metabolism in vivo
RB DeMattos et al.
NEURON (2004)
Marked regional differences of brain human apolipoprotein E expression in targeted replacement mice
PM Sullivan et al.
NEUROSCIENCE (2004)
Evaluation of the role of phosphatidylserine translocase activity in ABCA1-mediated lipid efflux
JD Smith et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice
RB DeMattos et al.
NEUROCHEMISTRY INTERNATIONAL (2001)
Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transporter
O Chambenoit et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Apolipoprotein A-I directly interacts with amyloid precursor protein and inhibits Aβ aggregation and toxicity
RP Koldamova et al.
BIOCHEMISTRY (2001)
Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project
F Schiele et al.
ATHEROSCLEROSIS (2000)
Measurement of apolipoprotein E (apoE) in cerebrospinal fluid
C Hesse et al.
NEUROCHEMICAL RESEARCH (2000)
Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease
A Merched et al.
NEUROBIOLOGY OF AGING (2000)